Back
8 July 2025
The ITA reports that athlete Imam Khataev was sanctioned with a two-year period of ineligibility after testing positive for Clomifene and its metabolites following an out-of-competition doping control on 9 April 2024.
Clomifene is prohibited under the WADA Prohibited List as S4 Hormone and Metabolic Modulators. It is prohibited at all times (in- and out-of-competition) and is classified as a specified substance. Clomifene can be used by athletes to increase testosterone levels.
The sanction was issued by the ITA on behalf of the IBA in accordance with article 8.3.3 of the IBA anti-doping rules (and equivalent provision in the World Anti-Doping Code).¹ The period of ineligibility is effective from 26 June 2025 until 25 June 2027 and the athlete’s results have been disqualified from 9 April 2024 onwards.
Parties with a right of appeal may challenge the decision before the appeals division of the Court of Arbitration for Sport (CAS) in accordance with article 13.2 of the IBA anti-doping rules.
The ITA will not comment further on this case.
¹ When an athlete does not challenge the assertion of an ADRV and does not request a hearing, anti-doping organisations have the possibility to issue a written decision sanctioning the athlete and imposing the applicable consequences without having to refer the case to a hearing panel. This is provided in articles 8.3.2 and 8.3.3 of the WAKO Anti-Doping Rules and article 8.3 of the World Anti-Doping Code.
